LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Canaccord Genuity 30th Annual Growth Conference on Thursday, August 12 at 1:30 p.m. (ET) in Boston.
